Source:http://linkedlifedata.com/resource/pubmed/id/20925464
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-10-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1744-8360
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1493-5
|
pubmed:meshHeading |
pubmed-meshheading:20925464-Brain Neoplasms,
pubmed-meshheading:20925464-Central Nervous System Diseases,
pubmed-meshheading:20925464-Disease Progression,
pubmed-meshheading:20925464-Glioma,
pubmed-meshheading:20925464-Humans,
pubmed-meshheading:20925464-Molecular Targeted Therapy,
pubmed-meshheading:20925464-Survival Rate,
pubmed-meshheading:20925464-Time Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
From survival to survivorship: late side effects become an issue in high-grade glioma.
|
pubmed:publicationType |
Editorial
|